Literature DB >> 12890905

Serum concentrations of vascular endothelial growth factor and monocyte-colony stimulating factor in peripheral arterial disease.

Keiji Matsui1, Toru Yoshioka, Yoshiaki Murakami, Masafumi Takahashi, Kazuyuki Shimada, Uichi Ikeda.   

Abstract

Vascular endothelial growth factor (VEGF) strongly promotes angiogenesis, and monocyte-colony stimulating factor (M-CSF) regulates the differentiation, proliferation, and survival of monocytes. Both VEGF and M-CSF are expressed in atherosclerotic lesions. The present study was performed to clarify the role of VEGF and M-CSF in the development of peripheral artery disease (PAD). The serum VEGF and M-CSF concentrations were determined in patients with arteriosclerosis obliterans (ASO) and thromboangitis obliterans (TAO). In both patient groups the serum VEGF concentrations were significantly higher than those in the control subjects. In contrast, the serum M-CSF concentrations in the ASO patients were significantly higher than those in both the TAO patients and control subjects, but there were no differences in the M-CSF concentrations between the TAO patients and control subjects. There was no correlation between the serum concentrations of VEGF and M-CSF. In conclusion, the serum VEGF concentration was increased in ASO and TAO patients, but increased concentration of M-CSF was seen only in ASO patients. These results may reflect a difference between ASO and TAO in disease pathogenesis.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12890905     DOI: 10.1253/circj.67.660

Source DB:  PubMed          Journal:  Circ J        ISSN: 1346-9843            Impact factor:   2.993


  6 in total

1.  Amelioration of Atherosclerosis by the New Medicinal Mushroom Grifola gargal Singer.

Authors:  Etsuko Harada; Corina N D'Alessandro-Gabazza; Masaaki Toda; Toshihiro Morizono; Ayshwarya-Lakshmi Chelakkot-Govindalayathil; Ziaurahman Roeen; Masahito Urawa; Taro Yasuma; Yutaka Yano; Toshimitsu Sumiya; Esteban C Gabazza
Journal:  J Med Food       Date:  2015-03-23       Impact factor: 2.786

2.  Analysis of G(-174)C IL-6 polymorphism and plasma concentrations of inflammatory markers in patients with type 2 diabetes and peripheral arterial disease.

Authors:  M Libra; S S Signorelli; Y Bevelacqua; P M Navolanic; V Bevelacqua; J Polesel; R Talamini; F Stivala; M C Mazzarino; G Malaponte
Journal:  J Clin Pathol       Date:  2006-02       Impact factor: 3.411

3.  Association of Acroosteolysis With Enhanced Osteoclastogenesis and Higher Blood Levels of Vascular Endothelial Growth Factor in Systemic Sclerosis.

Authors:  Jin Kyun Park; Andrea Fava; John Carrino; Filippo Del Grande; Antony Rosen; Francesco Boin
Journal:  Arthritis Rheumatol       Date:  2016-01       Impact factor: 10.995

4.  Activation of cytokines corroborate with development of inflammation and autoimmunity in thromboangiitis obliterans patients.

Authors:  R Dellalibera-Joviliano; E E Joviliano; J S Silva; P R B Evora
Journal:  Clin Exp Immunol       Date:  2012-10       Impact factor: 4.330

5.  Circulating angiogenic factors in patients with thromboangiitis obliterans.

Authors:  Bernd Hewing; Verena Stangl; Karl Stangl; Kathrin Enke-Melzer; Gert Baumann; Antje Ludwig
Journal:  PLoS One       Date:  2012-04-10       Impact factor: 3.240

6.  [Intervention of Vascular Dysplasia Caused by Different Mechanisms - Anlotinib for Right Lung Squamous Cell Carcinoma Combined with Thromboangiitis Obliterans: A Case Report and Literature Review].

Authors:  Huijuan Hao; Min Zhang; Guoqing Zhang; Hui Zhu; Wuping Bao
Journal:  Zhongguo Fei Ai Za Zhi       Date:  2020-01-20
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.